Does Alvesco (ciclesonide) cause side effects?
Alvesco (ciclesonide) is a man-made steroid for inhalation in the glucocorticoid family. It is related to the naturally-occurring steroid hormone, cortisol or hydrocortisone, produced by the adrenal glands.
The body converts ciclesonide to des-ciclesonide, which is the active form of the drug. Glucocorticoid steroids have potent anti-inflammatory actions. When used as an inhaler, Alvesco travels to the airways in the lung.
In people with asthma, the suppression of inflammation within the airways reduces the spasm of muscle cells that surround the airways as well as the accumulation of fluid and cells that accompanies the inflammation which lead to narrowing of the airways.
The narrowing makes it difficult to get air into and out of the lungs. When used in lower doses, very little Alvesco is absorbed into the body. When higher doses are used, Alvesco is absorbed and may cause side effects elsewhere in the body.
Common side effects of Alvesco include
- unpleasant taste in the mouth,
- dry mouth,
- burning or irritation in the mouth,
- runny or stuffy nose,
- sore throat,
- mild itching or skin rash,
- joint pain,
- back pain, and
Serious side effects of Alvesco include
- bronchospasm and
- worsening of existing viral, bacterial, fungal, or parasitic infections such as
Drug interactions of Alvesco include drugs such as ketoconazole that reduce the activity of liver enzymes that breakdown drugs may increase the levels of des-ciclesonide, which is the active form of Alvesco, and lead to increased exposure of the body to des-ciclesonide and more side effects.
Use of Alvesco during pregnancy has not been adequately evaluated.
It is unknown if Alvesco is secreted in breast milk. Other medications in this class are secreted into breast milk.
It is unknown if the small amounts of Alvesco that may appear in breast milk have an effect on the infant. Consult your doctor before breastfeeding.
What are the important side effects of Alvesco (ciclesonide)?
Alvesco (ciclesonide) side effects list for healthcare professionals
Systemic and local corticosteroid use may result in the following:
- Candida albicans infection
- Hypercorticism and adrenal suppression
- Growth effects
- Glaucoma and cataracts
Clinical Trial Experience
- The safety data described below for adults and adolescents 12 years of age and older reflect exposure to Alvesco in doses ranging from 80 mcg to 640 mcg twice daily in five double-blind placebo-controlled clinical trials.
- Studies with once daily dosing are omitted from the safety database because the doses studied once daily are lower than the highest recommended twice daily doses.
- The five studies were of 12 to 16 weeks treatment duration, one of which included a safety extension follow up of one year. In the 12 to 16 week treatment studies, 720 patients (298 males and 422 females) aged 12 years and older were exposed to Alvesco.
- In the long-term safety trial, 197 patients (82 males and 115 females) with severe persistent asthma from one of the 12-week trials were re-randomized and treated for up to one year with Alvesco 320 mcg twice daily. Safety information for pediatric patients 4 to 11 years of age, is obtained from once daily dosing studies.
- Two of these studies were designed with a 12-week double-blind treatment period followed by a long-term open label safety extension of one year, and one study was an open label safety study of one year duration.
- Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Adult and Adolescent 12 Years of Age and Older
- Four of the five trials included a total of 624 patients ages 12 years and older (359 females and 265 males) with asthma of varying severity who were treated with Alvesco 80 mcg, 160 mcg, or 320 mcg twice daily for 12 to 16 weeks.
- These studies included patients previously using either controller therapy (predominantly inhaled corticosteroids) or reliever therapy (bronchodilator therapy alone).
- In these trials, the mean age was 39.1 years, and the majority of the patients (79.0%) were Caucasian.
- In these trials, 52.3%, 59.8% and 54.1% of the patients in the Alvesco 80 mcg, 160 mcg, and 320 mcg treatment groups, respectively, had at least one adverse event compared to 58.0% in the placebo group.
- Table 1 includes adverse reactions for the recommended doses of Alvesco that occurred at an incidence of ≥ 3% in any of the Alvesco groups and which were more frequent with Alvesco compared to placebo.
Table 1: Adverse Reactions with ≥ 3%
Incidence Reported in Patients ≥ 12 Years of Age with Alvesco in US
Placebo-Controlled Clinical Trials in Patients Previously on Bronchodilators
and/or Inhaled Corticosteroids
|80 mcg BID
|160 mcg BID
|320 mcg BID
|Upper respiratory Inf.||6.5||7.1||8.7||4.1|
|Pain in extremity||1.0||0.3||3.1||2.3|
The following adverse reactions occurred in these clinical trials using Alvesco with an incidence of less than 1% and occurred at a greater incidence with Alvesco than with placebo.
- Infections and Infestations: Oral candidiasis
- Respiratory Disorders: Cough
- Gastrointestinal Disorders: Dry mouth, nausea
- General disorders and administrative site conditions: Chest discomfort
- Respiratory, Thoracic, and Mediastinal Disorders: Dysphonia, dry throat
The fifth study was a 12-week clinical trial in asthma patients 12 years of age and older who previously required oral corticosteroids (average daily dose of oral prednisone of 12 mg/day), in which the effects of Alvesco 320 mcg twice daily (n = 47) and 640 mcg twice daily (n = 49) were compared with placebo (n = 45) for the frequency of reported adverse reactions.
The following adverse reactions occurred at an incidence of ≥ 3% in the Alvesco-treated patients and were more frequent compared to placebo:
- oral candidiasis,
- back pain,
- musculoskeletal chest pain,
- face edema,
- fatigue, and
Pediatric Patients less than 12 Years of Age
- The safety of Alvesco in pediatric patients 4 to 11 years of age was evaluated in two studies in which Alvesco 40 mcg, 80 mcg, and 160 mcg was administered once daily for 12 weeks and in one study in pediatric patients 2 to 6 years of age in which Alvesco 40 mcg, 80 mcg, and 160 mcg was administered once daily for 24 weeks.
- Studies have not been conducted in patients less than 2 years of age.
Long-Term Clinical Trials Experience
- A total of 197 patients 12 years of age and older (82 males and 115 females) from one of the 12-week treatment placebo-controlled studies were re-randomized to ciclesonide 320 mcg twice daily and followed for one year.
- The safety profile from the one-year follow up was similar to that seen in the 12- and 16-week treatment studies.
- Long term safety information for pediatric patients 4 to 11 years of age is obtained from three open label one year safety studies.
In addition to adverse reactions identified from clinical trials, the following adverse reactions have been identified during worldwide post-marketing use of ciclesonide oral inhalation. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
What drugs interact with Alvesco (ciclesonide)?
- In clinical studies, concurrent administration of ciclesonide and other drugs commonly used in the treatment of asthma (albuterol, formoterol) had no effect on pharmacokinetics of desciclesonide.
- In vitro studies and clinical pharmacology studies suggested that des-ciclesonide has no potential for metabolic drug interactions or protein binding-based drug interactions.
- In a drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of desciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
Alvesco (ciclesonide) is a man-made steroid for inhalation in the glucocorticoid family. It is related to the naturally-occurring steroid hormone, cortisol or hydrocortisone, produced by the adrenal glands. Common side effects of Alvesco include unpleasant taste in the mouth, dry mouth, burning or irritation in the mouth, runny or stuffy nose, sore throat, hoarseness, mild itching or skin rash, joint pain, back pain, and headache. Use of Alvesco during pregnancy has not been adequately evaluated. It is unknown if Alvesco is secreted in breast milk.
Multimedia: Slideshows, Images & Quizzes
What Is Asthma? Symptoms, Causes, and Treatments
What is asthma? What is the main cause of asthma? Learn information about asthma, a chronic disease of the bronchiole tubes....
Asthma is a chronic disease of the airways of the lungs, which can be managed with proper treatment. Triggered by two main...
Asthma and Your Diet: Foods That Help and Hurt
Even though there's no specific asthma diet that can help your condition, certain foods may help or harm your breathing. Learn...
What is Asthma? Asthma Myths Debunked
What are asthma myths and facts? There is currently no cure for asthma, and no specific, single cause for asthma has been...
Asthma Attacks: Triggers, Symptoms, and Treatment
Asthma symptoms include coughing, wheezing, headache, fatigue, dark circles under the eyes, trouble sleeping, and loss of...
10 Worst Smog Cities in America
Learn the worst smog cities in America. See the 10 cities with the most polluted, unclean and smoggy air.
Asthma: Natural Ways to Ease Asthma Symptoms
You can do more than take medication to manage your asthma. Several other things can help you breathe more easily.
Related Disease Conditions
COPD vs. Asthma (Differences and Similarities)
COPD (chronic obstructive pulmonary disease) and asthma both have common symptoms like coughing, wheezing, shortness of breath, and a tight feeling in the chest. COPD is caused by tobacco smoking, while asthma is caused by your inherited genetic makeup and their interactions with the environment. Risk factors for asthma are obesity, exposure to cigarette smoke (even secondhand smoke), and personal history of hay fever. There is no cure for either disease, but symptoms can be managed with medication. A person with asthma has a better prognosis and life expectancy than someone with COPD.
Asthma is a condition in which hyperreactive airways constrict and result in symptoms like wheezing, coughing, and shortness of breath. Causes of asthma include genetics, environmental factors, personal history of allergies, and other factors. Asthma is diagnosed by a physician based on a patient's family history and results from lung function tests and other exams. Inhaled corticosteroids (ICS) and long-acting bronchodilators (LABAs) are used in the treatment of asthma. Generally, the prognosis for a patient with asthma is good. Exposure to allergens found on farms may protect against asthma symptoms.
Asthma Over-the-Counter Treatment
Patients who have infrequent, mild bouts of asthma attacks may use over-the-counter (OTC) medications to treat their asthma symptoms. OTC asthma medicines are limited to epinephrine and ephedrine. These OTC drugs are best used with the guidance of a physician, as there may be side effects and the drugs may not be very effective.
How Can I Treat My Child's Asthma at Home?
Treatment of a child's asthma involves following an action plan developed in consultation with your child's pediatrician. Severe asthmatic attacks require immediate medical attention and treatment at the hospital.
What Is the Treatment for Asthmatic Bronchitis?
Asthmatic bronchitis refers to inflammation of the bronchial tubes carrying air inside the lungs that occurs because of asthma. Treatment for asthmatic bronchitis involves bronchodilators, steroids, treating secretions, leukotriene inhibitors, antibiotics, oxygen administration and avoiding triggers.
There are two types of asthma medications: long-term control with anti-inflammatory drugs and quick relief from bronchodilators. Asthma medicines may be inhaled using a metered-dose inhaler or nebulizer or they may be taken orally. People with high blood pressure, diabetes, thyroid disease, or heart disease shouldn't take OTC asthma drugs like Primatene Mist and Bronkaid.
How Long Does Asthmatic Bronchitis Last?
The duration of the disease usually depends on the patient’s overall health and age. In patients with acute bronchitis symptoms may last less than 10 days. In patients with severe asthmatic bronchitis, the symptoms are recurrent and usually last between 30 days to even 2 years with flares and remissions.
Asthma in Children
Asthma in children manifests with symptoms such as coughing and wheezing. Rates of asthma in children are increasing. Asthma in children is usually diagnosed based on the description of symptoms. Lung function tests may also be used. A variety of medications are used for the treatment of childhood asthma.
Adult-onset asthma is asthma that is diagnosed in people over 20 years of age. Symptoms include wheezing, coughing, shortness of breath and difficulty breathing. Treatment may involve anti-inflammatory medications or bronchodilators.
What Is Asthma? 19 Complex Facts
There are many unusual symptoms of asthma, including sighing, difficulty sleeping, anxiety, chronic cough, recurrent walking pneumonia, and rapid breathing. These symptoms may vary from individual to individual. These asthma complexities make it difficult to accurately diagnose and treat asthma.
Can Asthma Go Away on Its Own?
Asthma is a long-term condition for many people, particularly if it first develops when you're an adult. In children, it sometimes goes away or improves during the teenage years, but can come back later in life.
What Are the Four Types of Asthma?
Asthma is a chronic inflammatory disease of the airways (bronchi). Bronchi generally allow for the passage of air in and out of the lungs. In asthma, these airways develop hypersensitivity, inflammation, and narrowing. This causes difficulty in breathing. The four types are mild intermittent, mild persistent, moderate persistent, and severe persistent.
Occupational asthma is a type of asthma caused by exposure to a substance in the workplace. Symptoms and signs include wheezing, chest tightness, and shortness of breath. The usual treatment for occupational asthma involves removal from exposure and the use of bronchodilators and inhaled anti-inflammatory medicines.
Treatment & Diagnosis
- Asthma FAQs
- What if I Get COVID-19 with Asthma?
- Methotrexate Spares Steroids in Asthmatics
- Asthma Rates Increasing
- Exercise Preventing Asthma?
- Asthma in Women, Asthma in Pregnancy
- Can Asthma Go Away and Come Back?
- What Are the Side Effects of Asthma Inhalers?
- Does Altitude Affect Asthma?
- What Is Exercise-Induced Asthma?
- Can Asthma Medication Hide Churg-Strauss Syndrome?
- Best Exercises for Asthma: Yoga, Swimming, Biking, and Walking
- Does Stress Cause Asthma?
- Can Asthma Cause a Heart Attack?
- What Causes Asthma?
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.